Aspivix

Aspivix

Medical Devices, Route De La Corniche 8, Epalinges, , 1066, New Jersey, United States, 1-10 Employees

aspivix.com

  • LinkedIn

phone no Phone Number: +15*********

Who is ASPIVIX

Aspivix is a medical device company in womens health, based in Switzerland, developing next-generation devices for gynecology. Our flagship product, CarevixTM, is the worlds first suction...

Read More

map
  • Route De La Corniche 8, Epalinges, New Jersey, 1066, United States Headquarters: Route De La Corniche 8, Epalinges, New Jersey, 1066, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Billion and Over
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 339112 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ASPIVIX

Aspivix Org Chart and Mapping

Employees

Susan Fidsa

Board Member, Chairperson

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Aspivix

Answer: Aspivix's headquarters are located at Route De La Corniche 8, Epalinges, , 1066, New Jersey, United States

Answer: Aspivix's phone number is +15*********

Answer: Aspivix's official website is https://aspivix.com

Answer: Aspivix's revenue is $1 Billion and Over

Answer: Aspivix's SIC: 3841

Answer: Aspivix's NAICS: 339112

Answer: Aspivix has 1-10 employees

Answer: Aspivix is in Medical Devices

Answer: Aspivix contact info: Phone number: +15********* Website: https://aspivix.com

Answer: Aspivix is a medical device company in womens health, based in Switzerland, developing next-generation devices for gynecology. Our flagship product, CarevixTM, is the worlds first suction cervical stabilizer clinically proven to reduce pain and bleeding associated with transcervical procedures commonly performed in gynecology, including IUD insertion, hysteroscopy, cervical biopsies, fertility treatments, and more. CarevixTM is a medical device that has received in 2023 FDA-clearance for the US market, as well as the CE-Mark for the European countries. CarevixTM study published in the international journal, Contraception, in March 2023 demonstrated superiority over the use of a single tooth tenaculum, reducing the pain by up to 73% and the bleeding by up to 78% in IUD insertions. More than 100 million women worldwide have procedures using the antiquated single-tooth tenaculum, an instrument invented over a century ago, without consideration of a woman's anatomy or pain, and yet it is still considered to be the standard of care in gynecology. At Aspivix, we think women deserve more. We are driven by our vision to make gynecology modern.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access